Stay updated on Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page header shows Revision: v3.3.4 and removes Revision: v3.3.3, a minor metadata update with no impact on study details or user workflow. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-17T01:10:07.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page footer was updated to Revision: v3.3.3 with the HHS Vulnerability Disclosure link removed and the previous Revision: v3.3.2 notice no longer shown. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-19T10:39:48.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2. The previous Revision: v3.3.1 has been removed.
    Difference
    0.1%
    Check dated 2025-11-28T00:23:09.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1 is shown on the page.
    Difference
    0.1%
    Check dated 2025-11-20T22:23:51.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The funding/operating status notice at the bottom of the page has been removed. This change affects only non-substantive site boilerplate and does not alter the study details or eligibility criteria.
    Difference
    0.4%
    Check dated 2025-11-13T16:00:41.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The updated page shows minor UI/formatting changes without any modification to core study details such as enrollment, status, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-30T11:11:28.000Z thumbnail image

Stay in the know with updates to Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.